We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-13.49%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$42.1B
AUM Growth
-$7.13B
Cap. Flow
+$617M
Cap. Flow %
1.47%
Top 10 Hldgs %
24.6%
Holding
2,253
New
45
Increased
584
Reduced
402
Closed
95

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$209M
2
T icon
AT&T
T
+$156M
3
XOM icon
ExxonMobil
XOM
+$122M
4
JNJ icon
Johnson & Johnson
JNJ
+$84.2M
5
WMT icon
Walmart Inc
WMT
+$77.1M

Sector Composition

Rank Sector Weight
1 Technology 20.42%
2 Healthcare 18.92%
3 Financials 13.22%
4 Consumer Discretionary 8.69%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDUP icon
2101
ThredUp
TDUP
$736M
$32K ﹤0.01%
12,860
FMTX
2102
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$32K ﹤0.01%
4,580
UBA
2103
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
-2,000
Closed -$34.6K
GNK icon
2104
Genco Shipping & Trading
GNK
$1.17B
$31K ﹤0.01%
1,580
NBP
2105
NovaBridge Biosciences American Depositary Shares
NBP
$205M
$31K ﹤0.01%
2,700
OZON
2106
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$31K ﹤0.01%
2,750
SERA icon
2107
Sera Prognostics
SERA
$80.3M
$30K ﹤0.01%
18,108
BROS icon
2108
Dutch Bros
BROS
$8.78B
$29K ﹤0.01%
+910
New +$37.3K
TPIC
2109
DELISTED
TPI Composites
TPIC
$29K ﹤0.01%
2,350
CGEM icon
2110
Cullinan Oncology
CGEM
$1.05B
$27K ﹤0.01%
2,070
IGMS
2111
DELISTED
IGM Biosciences
IGMS
$27K ﹤0.01%
1,480
-45,388
-97% -$809K
ESGR
2112
DELISTED
Enstar Group
ESGR
$26K ﹤0.01%
+120
New +$27.9K
HUMA icon
2113
Humacyte
HUMA
$168M
$25K ﹤0.01%
7,940
GRWG icon
2114
GrowGeneration
GRWG
$82.9M
$24K ﹤0.01%
6,610
VERX icon
2115
Vertex
VERX
$1.92B
$24K ﹤0.01%
2,120
LYLT
2116
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$24K ﹤0.01%
6,620
NEXT icon
2117
NextDecade
NEXT
$1.85B
$23K ﹤0.01%
+5,110
New +$31.7K
ALKT icon
2118
Alkami Technology
ALKT
$1.8B
$22K ﹤0.01%
1,570
BOC icon
2119
Boston Omaha
BOC
$429M
$22K ﹤0.01%
1,060
CHCO icon
2120
City Holding Co
CHCO
$1.97B
$22K ﹤0.01%
270
STTK icon
2121
Shattuck Labs
STTK
$710M
$22K ﹤0.01%
5,360
KLRS
2122
Kalaris Therapeutics
KLRS
$88.7M
$22K ﹤0.01%
250
CSTL icon
2123
Castle Biosciences
CSTL
$749M
$20K ﹤0.01%
890
KC
2124
Kingsoft Cloud Holdings
KC
$2.84B
$20K ﹤0.01%
4,400
PRPL icon
2125
Purple Innovation
PRPL
$33.2M
$20K ﹤0.01%
260

Similar funds

Ensign Peak Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Ensign Peak Advisors held 2,253 positions worth $42.1B, down 14% from $49.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ensign Peak Advisors's Q2 2022 filing shows 45 new, 584 increased, 402 reduced and 95 closed positions. Its largest new stake was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M. The largest sale was iShares Russell 2000 ETF, an estimated $209M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q2 2022 buy was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M.
  • Ensign Peak Advisors added most to Merck in Q2 2022, an estimated $209M increase.
  • Ensign Peak Advisors's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $209M.
  • Ensign Peak Advisors fully exited VMware, Inc in Q2 2022, selling an estimated $20.8M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $42.1B portfolio in Q2 2022.
  • Ensign Peak Advisors opened 45 new positions and closed 95 in Q2 2022.
  • Ensign Peak Advisors's portfolio value fell 14% quarter-over-quarter to $42.1B.

Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.